Position in ALNY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$493,087
+$21,598 QoQ
Shares Held
1,638
+14.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#483
of 786 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STEPHENS INC /AR/ holds $5,988,068 across 12 Biotechnology names. ALNY ranks #7 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,900 | $1,440,517 | |
| 2 | TECH |
BIO-TECHNE Corp
|
12,036 | $850,343 | |
| 3 | TWST |
Twist Bioscience Corp
|
5,167 | $531,580 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
831 | $518,161 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
1,625 | $513,646 | |
| 6 | EXEL |
Exelixis, Inc.
|
9,079 | $493,988 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,638 | $493,087 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,954 | $387,749 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493,087 | 1,638 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $471,489 | 1,425 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $336,014 | 845 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $318,744 | 699 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $207,067 | 635 | Shares | Defined | 2025-07-29 | |
| No filing history on record for this holder in this stock. | ||||||